List of Excipients in API fingolimod hydrochloride
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing fingolimod hydrochloride
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 | FERRIC OXIDE YELLOW |
| Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 | FERROSOFERRIC OXIDE |
| Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 | GELATIN |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for fingolimod hydrochloride
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
fingolimod hydrochloride drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
| >Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
fingolimod hydrochloride drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
| Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
| >Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
fingolimod hydrochloride drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
| Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
| >Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
fingolimod hydrochloride drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
| Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
| >Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
fingolimod hydrochloride drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
| Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
| >Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
fingolimod hydrochloride drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
| Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
| >Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
fingolimod hydrochloride drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
| >Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
fingolimod hydrochloride drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
| Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
| >Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
fingolimod hydrochloride drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
| >Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
fingolimod hydrochloride drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | fingolimod hydrochloride | 16729-342 |
| Ascend Laboratories LLC | fingolimod hydrochloride | 67877-476 |
| >Company | >Ingredient | >NDC |
fingolimod hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
